Background The safety of early anticoagulation in chronic subdural hematoma (cSDH) patients treated with surgery, with or without middle meningeal artery embolization (MMAE), remains unclear. This ...

Correspondence to Dr Jeremy J Heit, Department of Radiology, Neuroimaging and Neurointervention, Stanford University Hospital, 300 Pasteur Drive, S0047 Stanford, CA 94305, USA; jheit{at}stanford.edu ...

Introduction Mechanical thrombectomy (MT) is increasingly used for large-vessel occlusions (LVO), but randomized clinical trial (RCT) level data with regard to differences in clinical outcomes of MT ...

Background Intracranial atherosclerotic disease (ICAD) significantly contributes to ischemic stroke, especially among Asian populations. Large vessel occlusion (LVO) due to underlying ICAD accounts ...

Background Due to its high efficacy, flow diversion is increasingly used in the management of unruptured and recanalized aneurysms. Because of the need for perioperative dual antiplatelet treatment ...

3 Department of Endovascular Surgery, Jichi Medical University, Shimotsuke, Japan Correspondence to Dr Naoki Kaneko, Department of Neurosurgery, Jichi Medical University, 3311-1, Yakushiji, Shimotsuke ...

Correspondence to Dr Santiago Ortega-Gutierrez, Division of Neurointerventional Surgery-Interventional Neuroradiology, The University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA; ...

Cerebrovascular and Endovascular Division, Department of Neurosurgery, Tufts Medical Center, and Tufts University School of Medicine, Boston, Massachusetts, USA Correspondence to Dr A M Malek, ...

Treatment of wide-necked complex intracranial aneurysms continues to challenge neurointerventionalists. Intrasaccular flow diverters have expanded the armamentarium considerably and are now used ...

Background Intra-saccular Flow Disruptors (IFDs) are reliable devices to treat wide-neck bifurcation aneurysms. Hemodynamics plays a critical role in the prognosis of postoperative outcome. However, ...

Introduction Inflammation plays an important role in mediating morbidity following subarachnoid hemorrhage (SAH), including the development of cerebral vasospasm and hospital-acquired infections.

Background Malignant gliomas continue to have a poor clinical outcome with available therapies. In the past few years, new targeted biologic therapies have been studied, with promising results.